- Home
- PFO vs DTIL Comparison
PFO vs DTIL Comparison
Compare PFO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFO | DTIL |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.3M | 115.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PFO | DTIL |
|---|---|---|
| Price | $9.44 | $4.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $47.00 |
| AVG Volume (30 Days) | 31.8K | ★ 197.8K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $698,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.90 | $3.61 |
| 52 Week High | $8.51 | $8.82 |
Technical Indicators
Market Signals| Indicator | PFO | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 32.43 |
| Support Level | $9.38 | $4.67 |
| Resistance Level | $9.49 | $5.04 |
| Average True Range (ATR) | 0.09 | 0.32 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 46.02 | 1.15 |
Price Performance
Historical ComparisonAbout PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.